Literature DB >> 9596014

Deterioration of multifocal motor neuropathy after plasma exchange.

M Carpo1, A Cappellari, G Mora, R Pedotti, S Barbieri, G Scarlato, E Nobile-Orazio.   

Abstract

We report a patient with motor neuropathy in whom plasma exchange (PE) was followed by a pronounced clinical worsening with the appearance of conduction blocks in previously clinically unaffected motor nerves, leading to the diagnosis of multifocal motor neuropathy (MMN). This report highlights the different response to therapy of MMN and chronic inflammatory demyelinating polyneuropathy (CIDP) because not only steroids but also PE, which is often effective in CIDP, do not improve and at times may even worsen MMN.

Entities:  

Mesh:

Year:  1998        PMID: 9596014     DOI: 10.1212/wnl.50.5.1480

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

Review 1.  Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies.

Authors:  Lotte Vlam; W-Ludo van der Pol; Elisabeth A Cats; Dirk C Straver; Sanneke Piepers; Hessel Franssen; Leonard H van den Berg
Journal:  Nat Rev Neurol       Date:  2011-11-22       Impact factor: 42.937

Review 2.  Update on therapy of chronic immune-mediated neuropathies.

Authors:  Chiara Briani; Dario Cocito; Marta Campagnolo; Pietro Emiliano Doneddu; Eduardo Nobile-Orazio
Journal:  Neurol Sci       Date:  2021-01-16       Impact factor: 3.307

Review 3.  [Plasma exchange as a therapeutic option in neurological disorders].

Authors:  H C Lehmann; H P Hartung; G R Hetzel; B C Kieseier
Journal:  Nervenarzt       Date:  2007-02       Impact factor: 1.214

Review 4.  Intravenous immunoglobulin therapy in neurological diseases during pregnancy.

Authors:  Isabel Ringel; Uwe K Zettl
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

Review 5.  Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.

Authors:  Norman Latov
Journal:  Nat Rev Neurol       Date:  2014-07-01       Impact factor: 42.937

Review 6.  Multifocal motor neuropathy: current therapies and novel strategies.

Authors:  Eduardo Nobile-Orazio; Francesca Gallia
Journal:  Drugs       Date:  2013-04       Impact factor: 9.546

Review 7.  Chronic inflammatory demyelinating polyneuropathies: current treatment strategies.

Authors:  Thomas B Toothaker; Thomas H Brannagan
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

Review 8.  The Importance of Rare Subtypes in Diagnosis and Treatment of Peripheral Neuropathy: A Review.

Authors:  Brian C Callaghan; Raymond S Price; Kevin S Chen; Eva L Feldman
Journal:  JAMA Neurol       Date:  2015-12       Impact factor: 18.302

Review 9.  Treatment of dys-immune neuropathies.

Authors:  Eduardo Nobile-Orazio
Journal:  J Neurol       Date:  2005-04       Impact factor: 4.849

Review 10.  IVIg in idiopathic autoimmune neuropathies: analysis in the light of the latest results.

Authors:  Eduardo Nobile-Orazio; Fabrizia Terenghi
Journal:  J Neurol       Date:  2005-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.